Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 5:47 pm Sale |
2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Venrock Healthcare Capital Partners III, L.P. | 1,098,996 9.900% |
-30,101 (-2.67%) |
Filing |
| 2025-05-15 5:44 pm Purchase |
2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Venrock Healthcare Capital Partners III, L.P. | 417,541 9.900% |
417,541 (New Position) |
Filing |
| 2024-12-04 4:15 pm Purchase |
2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX |
Venrock Healthcare Capital Partners III, L.P. | 1,129,097 9.990% |
1,129,097 (New Position) |
Filing |